◆ SpookStack

° my , -l- FD-302 (Rev. 10-6-95) FEDERAL BUREAU OF INVESTIGATION ALL INFORMATION CONTAINED . HEREIN IS UNCLASSIFIED DATE l2@-10-2000 BY 60324 UC BAW/RS/STW Date of transcription LL / 14/2001 After Ging advised of the nature o he- Interview and the identities of the interviewing’ agents, provided the following information. the Unite oLvensive biological weapons program until President Nixon disgOntinued the program in 1969. After that, little work was ashe at USAMRIID, such as research regarding Legionnaires Dis@éase. Following an accidental release of anthrax in 1979 in Sverdlovsk, USSR, interest in defensive research at USAMRIID was renewed. Since then, USAMRIID has been occupied with research into diagnosis of disease, detection of microorganisms, serology, and vaccine development. Much of the vaccine research is done in the Bacteriology Division, Tests have also been conducted into the effectiveness o aerosolization of anthrax against monkeys. These tests were with the Federal Grand Jury subpoena originated in the Miami Division. USAMRIID has several hundred strains of bacillus anthracis (commonly known as anthrax) in its inventory. (A complete list is being collected in accordance with the subpoena from the Miami Division.) USAMRIID began collecting samples in the early 1980's. USAMRIID first_obtained the Ames strain in the earl 1980's A researcher named obtained the strain from a veterinary lab in Ames, Iowa. The lab obtained the sample from a cow that had died from anthrax a short time before. The entire anthrax collection at USAMRIID has been fully characterized. This has been accomplished by plasmid profile, antibiotic resistance, and staining for antibodies. Genetic sequencing has not been bE performed. For the research that has been conducted at USAMRIID in the past, this step has not been necessary. RFLP will be done in the future, however. Fort Detrick, Maryland Investigation on 11/09/2001 at — This document contains neither recommendations nor conclusions of the FBI. It is the property of the 0 your agency; ‘ it and its contents are not to be distributed outside your agency.